1AI 0.00% 1.0¢ algorae pharmaceuticals limited

Ann: NTCELL and Parkinson's Clinical Trial Update, page-8

  1. 16,605 Posts.
    lightbulb Created with Sketch. 2365
    That announcement shows also the problem they have with the small numbers and the statistics for the trial at 26 weeks, and that is the variability in the responses of the individual patients which was reflected in the size of the error bars. The lack of consistency in response between individual patients makes it more difficult to clearly show statistically that the treatment works better than placebo, at least until the placebo effect wears off.

    We have to wait.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $16.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $2.099K 209.8K

Buyers (Bids)

No. Vol. Price($)
8 4988309 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 1307268 9
View Market Depth
Last trade - 10.00am 19/06/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.